Clinical trial
Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg…
NCT00152880 · University Health Network, Toronto, Other · Unknown status
Key facts
| NCT number | NCT00152880 |
|---|---|
| Title | Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg Negative |
| Official title | Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg Negative, Have Normal ALT, and HBV DNA ≥10,000 Copies/mL |
| Lead sponsor | University Health Network, Toronto, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Hepatitis B |
| Enrollment | 30 |
| Start date | Jul 1, 2005 |
| First posted | Sep 9, 2005 |
| Last update posted | Dec 1, 2005 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: